Andy Batts
Long only, value, growth, momentum

Alphatec: Growth Prospects Suggest The Stock Could Be Significantly Undervalued

The outlook for the global spine surgery devices market has improved significantly over the last few months. In 2012 and the first half of 2013, spine surgical device makers had experienced a temporary pricing pressure and reimbursement challenges. Although the reimbursement challenges still remain, technological advancements coupled with an ageing population are causing a tremendous turnaround of this market, which was previously expected to grow at a CAGR of 5.1% over the next four years and reach $14.8 billion by 2017.

Alphatec Spine, a wholly-owned subsidiary of Alphatec Holdings (NASDAQ:ATEC), is a small but growing player in spine surgery market with a market cap of just $212 million. I believe that Alphatec Spine could be a great investment...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details